Name: Recombinan Human Anti-PD1 x Human Anti-LAG3 Bispecific Antibody (IgG(H)-scFv)
SKU: KN-0825-N31
Rating: 5 (1 reviews)

Recombinant Human Anti-PD1 x Human Anti-LAG3 Bispecific Antibody (IgG(H)-scFv) is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. The anti-PD1 scFvs are fused to the C terminus of the anti-LAG3 IgG-Fc chain. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can block PD-L1 and LAG3 signals, enhance T cell activation. It is designed for the research of Cancers therapy.

Datasheet INQUIRY

Specifications

Targets

PD1 & LAG3

Type

IgG-scFv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Cancers

Host Animal 1

Human

Host Animal 2

Human

Targets

Target 1

PD1

Gene ID

5133

UniProt ID

Q15116

Alternative Names

PDCD1; programmed cell death 1; PD1; PD-1; CD279; SLEB2; hPD-1; hPD-l; hSLE1; programmed cell death protein 1; protein PD-1; systemic lupus erythematosus susceptibility 2

Target 2

LAG3

Gene ID

3902

UniProt ID

P18627

Alternative Names

Lymphocyte activation gene 3 protein; LAG3; CD223; FDC; Protein FDC

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinan Human Anti-PD1 x Human Anti-LAG3 Bispecific Antibody (IgG(H)-scFv) (KN-0825-N31). Click the button below to contact us or submit your feedback about this product.

Recombinan Human Anti-PD1 x Human Anti-LAG3 Bispecific Antibody (IgG(H)-scFv) (CAT#: KN-0825-N31)

Specifications

Targets

Customer Reviews and Q&As